Rankings
▼
Calendar
OMER Q1 2020 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena
OMER
Omeros Corporation
$821M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$24M
+8.1% YoY
Gross Profit
$23M
98.9% margin
Operating Income
-$24M
-100.6% margin
Net Income
-$29M
-123.3% margin
EPS (Diluted)
$-0.53
QoQ Revenue Growth
-29.6%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$118M
Total Liabilities
$250M
Stockholders' Equity
-$132M
Cash & Equivalents
$7M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$24M
$22M
+8.1%
Gross Profit
$23M
$22M
+7.5%
Operating Income
-$24M
-$19M
-23.1%
Net Income
-$29M
-$24M
-19.2%
← FY 2020
All Quarters
Q2 2020 →